Medicapedia ESENCA
Image of Colonoscopy
Image: Wikimedia Commons

Colonoscopy

1969 · endoscopic examination of the large bowel

Share:FacebookWhatsApp

For much of medical history, the interior of the large bowel was hard to see. Physicians relied on the rectal examination with a finger and on rigid instruments that reached only short stretches, while many lesions, such as polyps (growths of the lining that can eventually turn into cancer) or hidden bleeding, were often found late.

Sigmoidoscopy improved matters by allowing a view of the final part of the colon, but most of the bowel remained unexplored. The decisive step came with flexible tubes made of optical fibres, which carry light and image along a curved path. The development, around 1969, of a flexible colonoscope with a camera at its tip is attributed to the Japanese researcher Shinya Watanabe, and it made the whole colon reachable without surgery.

The procedure requires preparation. For one to three days the patient follows a low-fibre diet or only clear liquids, and the day before a laxative or a polyethylene glycol wash clears the bowel of solid residue. In many cases the examination is done under deep sedation, a state of drug-induced unconsciousness in which the patient keeps breathing unaided and wakes quickly afterwards. The instrument advances through successive segments: rectum, sigmoid colon, descending, transverse and ascending colon, and caecum. Biopsies can be taken during the test, and polyps can be removed through endoscopic polypectomy.

The main gain is clear: removing polyps reduces the appearance of colon cancer. The evidence has not been free of debate, however. Several European Union countries rely mainly on faecal occult blood testing or sigmoidoscopy for population screening, whereas in the United States colonoscopy is the most recommended and widely used method. A large randomised trial, NordICC, with 84,585 participants aged 55 to 64 in Poland, Norway and Sweden, found an 18 per cent relative reduction in colorectal cancer risk after ten years, without a significant change in deaths from the disease or from any cause. Around 455 invitations were needed to prevent one case.

Today colonoscopy is also used to investigate lower digestive bleeding, inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and chronic diarrhoea. Complications are uncommon, mainly perforation of the colon and haemorrhage, and they are more likely when therapeutic procedures are performed. The American Society for Gastrointestinal Endoscopy estimates that about three in every thousand colonoscopies lead to serious complications.

Cost is also part of the picture. In 2021 the United States spent 43 billion dollars on screening for five types of cancer, and colonoscopies accounted for 55 per cent of that total. Colon cancer mortality has fallen steadily for about forty years, by nearly half since the 1980s, although the growth in screening does not appear to have accelerated that decline. Some therefore argue that resources should also go to wider access to effective treatment.

Key dates

  • 1969 Shinya Watanabe is credited with developing a flexible colonoscope using optical fibres.
  • 1980 Beginning of the decade from which colon cancer mortality starts a steady decline.
  • 2021 The United States spends 43 billion dollars on screening for five types of cancer, with colonoscopy accounting for 55 per cent.
  • 2026 The CONFIRM trial, comparing colonoscopy with the faecal immunochemical test, is still ongoing.
  • 2028 Planned date for the final follow-up of the CONFIRM trial.

Key figures: Shinya Watanabe

Curiosities and anecdotes

Few invitations accepted

In the NordICC trial, of the 28,220 people invited to a colonoscopy, only 11,843 (42 per cent) went through with it.

A test with a brand name

Among the colorectal cancer screening tests recommended in the United States is a stool DNA test known as Cologuard.

Sources

Original Medicapedia text based on:

Last updated: 5 November 2026 · How Medicapedia is made

A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.